(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals rising 4.12% to $4.80 on Thursday, following the last session’s downward trend. NASDAQ Composite rose 0.05% to $14,942.83, after three consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.


Today’s last reported volume for Inovio Pharmaceuticals is 3705370, 14.05% below its average volume of 4311430.

Inovio Pharmaceuticals’s last close was $4.79, 74.79% under its 52-week high of $19.00.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 311% for the current quarter and 132.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 400% and a negative 121.4%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 6.52M for the twelve trailing months.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $4.80 at 16:11 EST, way below its 52-week low of $5.75.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s value is way under its 50-day moving average of $6.91 and way under its 200-day moving average of $8.05.

More news about Inovio Pharmaceuticals (INO).


Please enter your comment!
Please enter your name here